No Image Available
Description
Gardasil 4 is a quadrivalent HPV vaccine that provides protection against four HPV types: 6, 11, 16, and 18. It is primarily used to prevent HPV-related diseases, including cervical cancer, genital warts, and other HPV-associated cancers.
Target Diseases
- Cervical Cancer: Caused by HPV types 16 and 18. Genital Warts: Caused by HPV types 6 and 11. Other HPV-related cancers
- including anal
- vulvar
- vaginal
- and oropharyngeal cancers.
Dosage Schedule
Ages 9–14 years: Two doses, given at 0 and 6–12 months. Ages 15 years and older: Three doses given at 0, 1–2 months, and 6 months.
Possible Side Effects
- common:%20Pain
- %20swelling
- %20or%20redness%20at%20the%20injection%20site;%20headache;%20fever;%20fatigue;%20nausea.%0ARare%3A%20Dizziness
- %20fainting%20(especially%20in%20adolescents)
- %20and%20severe%20allergic%20reactions%20(anaphylaxis).%0A
Contraindications
- Severe allergic reaction to any previous dose of an HPV vaccine or its components. Not recommended during pregnancy; vaccination should be postponed until after pregnancy.
Additional Information
- Gardasil 4 has significantly reduced the global burden of cervical cancer and other HPV-related conditions. It is part of national immunization programs in many countries and contributes to HPV elimination efforts worldwide. Pre-vaccination screening for HPV infection is not required; the vaccine is effective for preventing new infections.
Storage Requirements
- Store at 2°C–8°C (36°F–46°F). Do not freeze. Protect from ligh